A
10.88
0.07 (0.65%)
Market Trend
| Short Term | Medium Term | ||
| Industry | Drug Manufacturers - Specialty & Generic (US) | Mixed | Mixed |
| Drug Manufacturers - Specialty & Generic (Global) | Mixed | Mixed | |
| Stock | Alvotech | Bearish | Bullish |
Stockmoo Score
0.0
|
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases. |
|
| Sector | Healthcare |
| Industry | Drug Manufacturers - Specialty & Generic |
| Investment Style | Small Growth |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Bracebridge Capital, Llc | 30 Jun 2024 | 2,705,304 |
| Littlejohn & Co Llc | 30 Jun 2024 | 1,318,534 |
| Lodbrok Capital Llp | 30 Jun 2024 | 715,814 |
| Oaktree Fund Advisors, Llc | 30 Jun 2024 | 118,744 |
| 52 Weeks Range | ||
| Median | 18.00 (65.44%) | |
| Total | 1 Buy | |
| Firm | Date | Target Price | Call | Price @ Call |
|---|---|---|---|---|
| Barclays | 25 Jul 2024 | 18.00 (65.44%) | Buy | 11.29 |
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2024 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |